These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 3196393

  • 21. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV, Howes J, Sharma V, Kadziola Z.
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Mortality and morbidity of thromboembolism in drug prevention--5-year analysis].
    Hopp H, Hopp A, Knispel J.
    Zentralbl Gynakol; 1988 Apr; 110(9):562-9. PubMed ID: 3407358
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery.
    Steiner RA, Keller K, Lüscher T, Schreiner WE.
    Arch Gynecol Obstet; 1989 Apr; 244(3):141-50. PubMed ID: 2544152
    [Abstract] [Full Text] [Related]

  • 31. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.
    Haas S, Wolf H, Kakkar AK, Fareed J, Encke A.
    Thromb Haemost; 2005 Oct; 94(4):814-9. PubMed ID: 16270636
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Angiospasm and dihydroergotamine--dangers in thromboprevention].
    Schwering H, Rühland D.
    Zentralbl Chir; 1985 Oct; 110(18):1115-21. PubMed ID: 4082802
    [Abstract] [Full Text] [Related]

  • 34. [Heparin-dihydergot or heparin alone in thrombosis prophylaxis?].
    Koppenhagen K, Matthes M.
    Med Welt; 1982 Feb 12; 33(6):216-23. PubMed ID: 7070283
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prevention of fatal postoperative pulmonary embolism by heparin dihydroergotamine or Dextran 70.
    Gruber UF.
    Br J Surg; 1982 Jun 12; 69 Suppl():S54-8. PubMed ID: 6177371
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?].
    Rasche H, Vollmar J, Burri C, Beger HG, Kilian J, Kinzl J, Krautzberger W, Wenzke C.
    Langenbecks Arch Chir; 1983 Jun 12; 360(2):81-95. PubMed ID: 6355715
    [Abstract] [Full Text] [Related]

  • 40. [A combination of dihydroergotamine and acetylsalicylic acid--prevention of postoperative thromboembolic complications. Clinical study in orthopedics].
    Stern D, Vasey H.
    Schweiz Med Wochenschr; 1987 Dec 19; 117(51):2084-8. PubMed ID: 3433091
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.